Deyang Sinozyme Pharmaceutical Co., Ltd. is a Sino-German joint venture established in 2003, controlled by Sichuan Deebiotech Co., Ltd. The company is dedicated to the production of high-quality pharmaceuticals, specialising in the development and manufacturing of Active Pharmaceutical Ingredients (APIs) and natural extracts. Since its inception, Deyang Sinozyme has prioritised adherence to high international standards, achieving EU GMP certification in 2005. Its range of pancreatin series products is exported globally, including to Europe, America, Japan, and Korea, reinforcing the company’s commitment to quality in all its operations.

Services include:
– APIs (Active Pharmaceutical Ingredients)
– Natural Extracts

Deyang Sinozyme Pharmaceutical Co., Ltd. stands as a key supplier within the pharmaceutical industry, known for its focus on quality and compliance with global standards. For more information, please visit deebio.com.